Jefferies, BofA, Leerink, Guggenheim, Truist and LifeSci Capital acted as joint book running managers for the offering.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRUS:
- Merus’s Promising Clinical Developments and Market Potential Justify Buy Rating
- Closing Bell Movers: Guidewire up 11% after Q3 beat, guidance raise
- Merus announces common shares offering, no amount given
- Merus’s Strong Clinical Data and Financial Stability Justify Buy Rating
- Merus Announces Promising Phase 2 Trial Results